Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001306923-25-000009·Palo Alto Investors LP
Schedule 13G ownership disclosure
REVANCE THERAPEUTICS INC
Common Stock · CUSIP: 761330109
Event date: 2024-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Patrick Lee, MD
Shares: 1,611,787.00 · Class: 1.54%
- Anthony Joonkyoo Yun, MD
Shares: 1,611,787.00 · Class: 1.54%
- Palo Alto Investors LP
Shares: 1,611,787.00 · Class: 1.54%
- PAI LLC
Shares: 1,611,787.00 · Class: 1.54%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001306923-25-000009
- Form type
- SCHEDULE 13G/A
- Filer
- Palo Alto Investors LP
- CIK
- CIK 1306923
- Filed
- Feb 13, 2025
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership